Advances in Assay Technologies for CAR T-Cell Therapies

被引：1
|
作者：
Armstrong, Alison [1 ]
机构：
[1] BioReliance, Dev Serv, Rockville, MD 20850 USA
来源：
BIOPHARM INTERNATIONAL | 2016年 / 29卷 / 02期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：32 / +
页数：5
相关论文
共 50 条
  • [31] Advances in CAR T-Cell Therapy for Aggressive B-NHL
    Riedell, Peter A. y
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S94 - S97
  • [32] Recent advances in CAR T-cell toxicity: Mechanisms, manifestations and management
    Brudno, Jennifer N.
    Kochenderfer, James N.
    [J]. BLOOD REVIEWS, 2019, 34 : 45 - 55
  • [33] Update on CAR T-Cell Therapies for Relapsed/Refractory B-Cell Lymphomas
    Schuster, Stephen J.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 (5.5): : 622 - 624
  • [34] Advances in Chimeric Antigen Receptor T-Cell Therapies for Solid Tumors
    Baybutt, Trevor R.
    Flickinger, John C., Jr.
    Caparosa, Ellen M.
    Snook, Adam E.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 (01) : 71 - 78
  • [35] The PO4-tential for Less Toxic CAR T-cell Therapies
    Tobin, Joshua W. D.
    Green, Michael R.
    Gandhi, Maher K.
    [J]. CANCER IMMUNOLOGY RESEARCH, 2022, 10 (12) : 1422 - 1422
  • [36] Keynote Session: Experience With Innovative Therapies A Focus on CAR T-Cell Therapy
    不详
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (05): : 548 - 550
  • [37] Customer pyramid framework for CAR T-cell therapies in immuno-oncology
    Malik, Nafees N.
    Durdy, Matthew B.
    [J]. DRUG DISCOVERY TODAY, 2016, 21 (10) : 1563 - 1565
  • [38] European Myeloma Network perspective on CAR T-cell therapies for multiple myeloma
    Bruno, Benedetto
    Wasch, Ralph
    Engelhardt, Monika
    Gay, Francesca
    Giaccone, Luisa
    D'Agostino, Mattia
    Rodriguez-Lobato, Luis-Gerardo
    Danhof, Sophia
    Gagelmann, Nico
    Kroeger, Nicolaus
    Popat, Rakesh
    van de Donk, Niels W. C. J.
    Terpos, Evangelos
    Dimopoulos, Meletios A.
    Sonneveld, Pieter
    Einsele, Hermann
    Boccadoro, Mario
    [J]. HAEMATOLOGICA, 2021, 106 (08) : 2054 - 2065
  • [39] CAR T-cell therapies: formulation-product-proposition framework for commercialisation
    Malik, Nafees N.
    Durdy, Matthew B.
    [J]. DRUG DISCOVERY TODAY, 2016, 21 (11) : 1731 - 1734
  • [40] Ethical Prioritization of Patients to CAR T-Cell Therapies: Tool Development and Process
    Chen, Christine, I
    Bell, Jennifer A. H.
    [J]. BLOOD, 2022, 140 : 2406 - 2407
12345